SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 16th, 2022 • Akero Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 16th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 15, 2022, between Akero Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and Pfizer Inc., a corporation organized under the laws of the State of Delaware (the “Purchaser”).